title: Malaysian orthopaedic surgeons' approach to venous thromboembolic disease prophylaxis: attitudes and practice.
abstract: OBJECTIVE
  To survey Malaysian orthopaedic surgeons' attitudes to and use of venous thromboembolic disease prophylaxis.
  
  
  METHODS
  A total of 144 orthopaedic surgeons from various governmental and private institutions responded to a questionnaire.
  
  
  RESULTS
  Only slightly more than half of these surgeons considered venous thromboembolic disease as common a problem in Malaysia as in western countries. The majority of surgeons (91.0%) reported using prophylaxis selectively for patients based on various indicators such as risk grading of surgery, obesity, and malignancy etc. Bleeding tendencies were cited as the greatest fear against the use of pharmacological prophylaxis. Low-molecular-weight heparin appeared to be the most commonly used pharmacological prophylaxis, used either singly or in combination with other forms of prophylaxis. The majority of surgeons employed prophylaxis until their patients were mobile.
  
  
  CONCLUSIONS
  There should be greater awareness among surgeons in Malaysia of the need for protection against venous thromboembolic disease. Current practice needs to be reviewed and further recommendations made for existing protocols.
authors.affiliation: Orthopaedic Unit, Department of Surgery, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Hospital Kuala Lumpur, Jalan Masjid, 50586 Kuala Lumpur, Malaysia. znizam@medic.upm.edu.my
authors.forename: Z F
authors.initials: ZF
authors.lastname: Zairul-Nizam
authors.forename: Y A
authors.initials: YA
authors.lastname: Gul
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage*; D001291:Attitude of Health Personnel / Q000208:ethnology*; D001458:Bandages; D019538:Health Care Surveys; D006801:Humans; D008296:Malaysia; D009985:Orthopedics; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D013923:Thromboembolism / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors